Retrovirus, NIH, and a CAR-T cell walk into a bar… The beginning of the worst joke ever or a topic for an atypical Thursday afternoon talk.

Tomáš Kroupa is currently a Process Development Specialist at SCTbio in Prague. SCTbio is a Contract Development and Manufacturing Organization that produces cancer therapy and currently has one

CAR-T cell therapy in Phase I clinical trial. Tomáš obtained his Ph.D. in biochemistry at the University of Chemistry and Technology, Prague, and then spent 4.5 years as a Visiting Postdoctoral Fellow at the National Cancer Institute in the United States where he was a member of the Retrovirus Assembly Section of the HIV Dynamics and Replication Program studying recognition of viral genomic RNA for packaging.